Literature DB >> 12201589

Bancroftian filariasis infection, disease, and specific antibody response patterns in a high and a low endemicity community in East Africa.

Paul E Simonsen1, Dan W Meyrowitsch, Walter G Jaoko, Mwele N Malecela, Dunstan Mukoko, Erling M Pedersen, John H Ouma, Rwehumbisa T Rwegoshora, Naftal Masese, Pascal Magnussen, Benson B A Estambale, Edwin Michael.   

Abstract

Bancroftian filariasis infection, disease and specific antibody response patterns in a high and a low endemicity community in East Africa were analyzed and compared to assess the relationship between these parameters and community transmission intensity. Overall prevalences of microfilaremia and circulating filarial antigenemia were 24.9% and 52.2% in the high and 2.7% and 16.5% in the low endemicity community, respectively. A positive history of acute attacks of adenolymphangitis was given by 12.2% and 7.1% of the populations, 4.0% and 0.9% of the adult (> or = 20 years old) individuals presented with limb lymphedema, and 25.3% and 5.3% of the adult males had hydrocele, in the high and the low endemicity community, respectively. Both infection and disease appeared earlier and reached much higher levels in the high than in the low endemicity community. The observed overall and age-specific infection and disease patterns in the two communities were in agreement with the view that these are primarily shaped by transmission intensity. No statistically significant relationships between infection status of fathers and mothers and that of their children were observed in any of the communities for either microfilaremia or for circulating filarial antigenemia. The overall levels (prevalence and geometric mean intensity) of filarial-specific IgG1, IgG2, IgG4, and IgE were significantly higher in the high endemicity community than in the low endemicity dommunity. Surprisingly, the opposite pattern was found for IgG3. Community transmission intensity thus appears to be an important determinant of observed inter-community variation in infection, disease, and host response patterns in Bancroftian filariasis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12201589     DOI: 10.4269/ajtmh.2002.66.550

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  22 in total

1.  Is the current decline in malaria burden in sub-Saharan Africa due to a decrease in vector population?

Authors:  Dan W Meyrowitsch; Erling M Pedersen; Michael Alifrangis; Thomas H Scheike; Mwelecele N Malecela; Stephen M Magesa; Yahya A Derua; Rwehumbiza T Rwegoshora; Edwin Michael; Paul E Simonsen
Journal:  Malar J       Date:  2011-07-13       Impact factor: 2.979

2.  An Expanded Transmission Assessment Survey to Confirm the Interruption of Lymphatic Filariasis Transmission in Wallis and Futuna.

Authors:  Lorenzo Pezzoli; Sung Hye Kim; Jean Pierre Mathelin; Karen Hennessey; Padmasiri Eswara Aratchige; Jayaprakash Valiakolleri
Journal:  Am J Trop Med Hyg       Date:  2019-12       Impact factor: 2.345

3.  Increased early local immune responses and altered worm development in high-dose infections of mice susceptible to the filaria Litomosoides sigmodontis.

Authors:  Simon Babayan; Tarik Attout; Sabine Specht; Achim Hoerauf; Georges Snounou; Laurent Rénia; Masataka Korenaga; Odile Bain; Coralie Martin
Journal:  Med Microbiol Immunol       Date:  2004-08-26       Impact factor: 3.402

4.  Influence of maternal filariasis on childhood infection and immunity to Wuchereria bancrofti in Kenya.

Authors:  Indu Malhotra; John H Ouma; Alex Wamachi; John Kioko; Peter Mungai; Malik Njzovu; James W Kazura; Christopher L King
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

5.  Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.

Authors:  Paul E Simonsen; Erling M Pedersen; Rwehumbiza T Rwegoshora; Mwelecele N Malecela; Yahya A Derua; Stephen M Magesa
Journal:  PLoS Negl Trop Dis       Date:  2010-06-01

6.  Immunoepidemiology of Wuchereria bancrofti infection: parasite transmission intensity, filaria-specific antibodies, and host immunity in two East African communities.

Authors:  Walter G Jaoko; Edwin Michael; Dan W Meyrowitsch; Benson B A Estambale; Mwele N Malecela; Paul E Simonsen
Journal:  Infect Immun       Date:  2007-10-01       Impact factor: 3.441

7.  Evidence for stopping mass drug administration for lymphatic filariasis in some, but not all local government areas of Plateau and Nasarawa States, Nigeria.

Authors:  Jonathan D King; Abel Eigege; John Umaru; Nimzing Jip; Emmanuel Miri; Jonathan Jiya; Kal M Alphonsus; Yohanna Sambo; Patricia Graves; Frank Richards
Journal:  Am J Trop Med Hyg       Date:  2012-08       Impact factor: 2.345

8.  Impact of basic lymphedema management and antifilarial treatment on acute dermatolymphangioadenitis episodes and filarial antigenaemia.

Authors:  Ha El-Nahas; Am El-Shazly; M Abulhassan; Na Nabih; N Mousa
Journal:  J Glob Infect Dis       Date:  2011-07

9.  Concomitant infections of Plasmodium falciparum and Wuchereria bancrofti on the Kenyan coast.

Authors:  Ephantus J Muturi; Charles M Mbogo; Joseph M Mwangangi; Zipporah W Ng'ang'a; Ephantus W Kabiru; Charles Mwandawiro; John C Beier
Journal:  Filaria J       Date:  2006-05-24

10.  Spatial clustering of filarial transmission before and after a Mass Drug Administration in a setting of low infection prevalence.

Authors:  Charles H Washington; Jeanne Radday; Thomas G Streit; Heather A Boyd; Michael J Beach; David G Addiss; Rodrigue Lovince; Maribeth C Lovegrove; Jack G Lafontant; Patrick J Lammie; Allen W Hightower
Journal:  Filaria J       Date:  2004-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.